These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35463347)

  • 1. Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
    Rong X; Lv J; Liu Y; Wang Z; Zeng D; Li Y; Li S; Wu J; Shen Z; Shi M; Liao W; Wu Z; Wang C
    Front Oncol; 2022; 12():895938. PubMed ID: 35463347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment.
    Wang Y; Huang Q; Zhong G; Lv J; Guo Q; Ma Y; Wang X; Zeng J
    Front Oncol; 2024; 14():1376408. PubMed ID: 38476368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes.
    Chen L; Sun H; Zhao R; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Song H; Li X
    Front Pharmacol; 2022; 13():1079635. PubMed ID: 36452221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer.
    Lv H; Zhang J; Sun K; Nie C; Chen B; Wang J; Xu W; Wang S; Liu Y; Chen X
    Front Oncol; 2021; 11():672599. PubMed ID: 33959515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: CircHIPK3 Promotes Metastasis of Gastric Cancer
    Jin Y; Che X; Qu X; Li X; Lu W; Wu J; Wang Y; Hou K; Li C; Zhang X; Zhou J; Liu Y
    Front Oncol; 2021; 11():783320. PubMed ID: 34869038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: A Dual-Circular RNA Signature as a Non-invasive Diagnostic Biomarker for Gastric Cancer.
    Han L; Zhang X; Wang A; Ji Y; Cao X; Qin Q; Yu T; Huang H; Yin L
    Front Oncol; 2020; 10():1704. PubMed ID: 33072552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer.
    Zhao J; Chen S; Zhu L; Zhang L; Liu J; Xu D; Tian G; Jiang T
    Front Oncol; 2022; 12():1052763. PubMed ID: 36303831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.
    Hou T; Jiang S; Wang Y; Xie Y; Zhang H; Feng Y; Ma F; Ma J; Liu X; Hu C
    Front Oncol; 2021; 11():705406. PubMed ID: 34150669
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Jreige M; Letovanec I; Chaba K; Renaud S; Rusakiewicz S; Cristina V; Peters S; Krueger T; de Leval L; Kandalaft LE; Nicod-Lalonde M; Romero P; Prior JO; Coukos G; Schaefer N
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1859-1868. PubMed ID: 31214790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PD-L1 Negative Advanced Gastric Cancer Patient With a Long Response to PD-1 Blockade After Failure of Systematic Treatment: A Case Report.
    Zhang F; Zhang J; Zhao L; Zhai M; Zhang T; Yu D
    Front Immunol; 2021; 12():759250. PubMed ID: 34950137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.
    Ma W; Gilligan BM; Yuan J; Li T
    J Hematol Oncol; 2016 May; 9(1):47. PubMed ID: 27234522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.
    Chen Q; Tan Y; Zhang C; Zhang Z; Pan S; An W; Xu H
    Front Oncol; 2021; 11():683333. PubMed ID: 33937088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer.
    Zhu Y; Zhang R; Zhang Y; Cheng X; Li L; Wu Z; Ding K
    Front Oncol; 2023; 13():1240063. PubMed ID: 37700841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer.
    Frontiers Production Office
    Front Oncol; 2021; 11():715746. PubMed ID: 34222032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis.
    Zhang J; Zhang L; Duan S; Li Z; Li G; Yu H
    Front Oncol; 2023; 13():1200951. PubMed ID: 37483523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Prediction of EGFR Mutation Status Based on
    Yin G; Wang Z; Song Y; Li X; Chen Y; Zhu L; Su Q; Dai D; Xu W
    Front Oncol; 2021; 11():747316. PubMed ID: 34557420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
    Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
    Front Oncol; 2021; 11():666560. PubMed ID: 33834001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma.
    Xu F; Zhu W; Shen Y; Wang J; Xu R; Outesh C; Song L; Gan Y; Pu C; Hu H
    Front Oncol; 2020; 10():608365. PubMed ID: 33194775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression.
    Gong LB; Wen T; Li Z; Xin X; Che XF; Wang J; Liu YP; Qu XJ
    Front Oncol; 2022; 12():819244. PubMed ID: 35280738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.